|
⚲
|
| Keyboard |
| McComb Joel
✚
|
|
|---|---|
| CIK # | 0001429845 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001429845] | |
| 4 | [0001429845] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| McComb Joel | |
| Bio-Rad Laboratories Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2018-12-14 | Grant | 19,600 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2018-09-20 | Sell | 24,267 | $6.57 | 159,434 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2018-09-19 | Sell | 25,733 | $6.48 | 166,750 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2018-02-15 | Buy | 50,000 | $2.25 | 112,500 |
|
Peregrine Pharmaceuticals Inc PPHM
Stock Option (right to buy) · derivative
|
2017-11-27 | Grant | 75,000 | $0.00 |